key: cord-0931469-65r94svv authors: Bouzid, Donia; Zanella, Marie-Céline; Kerneis, Solen; Visseaux, Benoît; May, Larissa; Schrenzel, Jacques; Cattoir, Vincent title: Rapid diagnostic tests for infectious diseases in the emergency department date: 2020-02-29 journal: Clin Microbiol Infect DOI: 10.1016/j.cmi.2020.02.024 sha: 68fbef65ff633c5c0b2ec0b089f2316d18ccbd92 doc_id: 931469 cord_uid: 65r94svv BACKGROUND: Rapid diagnostic tests (RDTs) for infectious diseases, with a turn-around time <2 hours, are promising tools that could improve patient care, antimicrobial stewardship and infection prevention in the emergency department (ED) setting. Numerous RDTs have been developed but not necessarily for the ED environment. Their successful implementation in the ED relies on their performance and impact on patient management. OBJECTIVES: The aim of this narrative review is to provide an overview of currently available RDTs for infectious diseases in the ED. SOURCES: PubMed was searched through August 2019 for available studies on RDTs for infectious diseases. Inclusion criteria included: commercial tests approved by the FDA or CE-IVD with data on clinical samples, ability to run on fully-automated systems and result delivery within 2 hours. CONTENT: A non-exhaustive list of representative commercially available FDA or CE approved assays was categorized by clinical syndrome: pharyngitis and upper respiratory tract infection, lower respiratory tract infection, gastrointestinal infection, meningitis and encephalitis, fever in the returning traveler and sexually-transmitted infection including HIV. The performance of tests was described based on clinical validation studies. Further, their impact on clinical outcomes and anti-infective use was discussed with a focus on ED-based studies. IMPLICATIONS: Clinicians should be familiar with the distinctive features of each RDT and individual performance characteristics for each target. Their integration into ED workflow should be pre-planned considering local constraints of given settings. Additional clinical studies are needed to further evaluate their clinical and cost effectiveness. 59 Rapid diagnostic tests (RDTs) for infectious diseases have recently been implemented in 60 many laboratories and emergency departments (EDs) with the goal of expediting the 61 diagnosis of infectious diseases, infection prevention, appropriate initial management, and 62 to facilitate antimicrobial stewardship in the ED where rapid clinical decisions must be 63 undertaken in the context of overcrowding and time pressures [1] . Even though multiple 64 RDTs are currently available, their successful implementation in the ED requires careful 65 assessment of performance characteristics, potential benefits to patient care and cost 66 considerations, as well as a well-organized implementation plan to optimize their impact [2] . 67 The goal of this narrative review is to provide an overview of currently available RDTs for 68 infectious diseases in the ED with a detailed description of their performance and to discuss 69 their impact on patient care. RDTs for infectious diseases in ED department using the following MeSH and keywords: 74 viruses and some atypical bacteria: Bordetella pertussis, Bordetella parapertussis, 150 Chlamydophila pneumoniae and Mycoplasma pneumoniae. Analytical performance 151 characteristics, compared to reference PCR assays, are good to excellent (sensitivity and 152 specificity from 80 to 100% for all targets). Of note, some bacterial targets have been 153 validated with fewer than 10 positive samples, and performance characteristics of bacterial 154 PCR have sometimes been reported to be lower than those of viral PCR [19] , highlighting the 155 need for caution when interpreting cumulative performance results. Furthermore, the 156 performance of some panels ( [39] † The performance characterisƟcs of the assays are described as sensiƟvity and specificity according to published clinical validation studies when available. In the absence of test comparison against a gold standard assay, the reported positive and negative percent agreement in the clinical studies reviewed were not reported to avoid any misinterpretation by the reader. * Sensitivity has been extracted from the "acute infection" population and specificity has been extracted from the "naïve individuals" population described in the corresponding reference. Emergency department crowding: A 306 systematic review of causes, consequences and solutions Routine use of point-of-care tests: usefulness and application in clinical microbiology The point-of-care laboratory in clinical microbiology Improved Diagnostic 312 Performance of an Immunofluorescence-based Rapid Antigen Detection Test for Group A Streptococci in 313 Children With Pharyngitis Detection of Group A 315 Streptococcus in Pharyngeal Swab Specimens by Use of the AmpliVue GAS Isothermal Helicase-Dependent 316 Amplification Assay Diagnosis and antibiotic treatment of group a 318 streptococcal pharyngitis in children in a primary care setting: impact of point-of-care polymerase chain 319 reaction Potential for Molecular Testing for 321 Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective 322 Study Evaluation of the Sofia Streptococcus pneumoniae FIA 324 test for the detection of S. pneumoniae antigen in urine Detection of Legionella pneumophila antigen in urine samples 326 by the BinaxNOW immunochromatographic assay and comparison with both Binax Legionella Urinary 327 Enzyme Immunoassay (EIA) and Biotest Legionella Urin Antigen EIA Comparison of the illumigene Mycoplasma DNA amplification assay and 329 culture for detection of Mycoplasma pneumoniae Performance of the Cobas((R)) Influenza A/B Assay for Rapid Pcr-331 Based Detection of Influenza Compared to Prodesse ProFlu+ and Viral Culture Prospective evaluation of 334 three rapid molecular tests for seasonal influenza in patients presenting at an emergency unit Evaluation of Sofia fluorescent immunoassay 337 analyzer for influenza A/B virus Evaluation of Alere i RSV for Rapid Detection of 339 Respiratory Syncytial Virus in Children Hospitalized with Acute Respiratory Tract Infection Multi-center evaluation of 342 the cobas((R)) Liat((R)) Influenza A/B & RSV assay for rapid point of care diagnosis Clinical Impact of Rapid Point-of-Care Influenza Testing in an Urgent Care Setting: a Single-Center Study Respiratory Viruses by Multiplex PCR Assay on Clinical Outcomes in Adult Patients Impact of rapid influenza 425 diagnostic test on physician estimation of viral infection probability in paediatric emergency department 426 during epidemic period Diagnostic accuracy and cost analysis of 428 the Alere i Influenza A&B near-patient test using throat swabs Urinary Antigen Tests in Community-acquired Pneumonia: Prospective Evaluation of Indications for 431 Cost effectiveness of 433 pneumococcal urinary antigen in Emergency Department: a pragmatic real-life study Panel Implementation on Health Care Utilization and Outcomes A Gastrointestinal PCR Panel Improves Clinical 438 Management and Lowers Health Care Costs A National study of the 440 impact of rapid influenza testing on clinical care in the emergency department Point-of-care HIV RNA testing and 443 immediate antiretroviral therapy initiation in young adults seeking out-patient care in Kenya Comparing the treatment of patients tested for chlamydia and gonorrhea after a rapid polymerase chain 447 reaction test versus standard of care testing Use of a rapid diagnostic for Chlamydia 449 trachomatis and Neisseria gonorrhoeae for women in the emergency department can improve clinical 450 management: Report of a randomized clinical trial A Pragmatic Study to Evaluate the Use of a Rapid 452 Diagnostic Test to Detect Group A Streptococcal Pharyngitis in Children With the Aim of Reducing 453 Antibiotic Use in a UK Emergency Department Molecular Tests for Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses: A Systematic 456 Review of Diagnostic Accuracy and Clinical Impact Studies False negative diagnostic errors with 475 polymerase chain reaction for the detection of cryptococcal meningoencephalitis Infants Aged 1 to 60 Days with Residual Cerebrospinal Fluid (CSF) Tested Using the FilmArray 478 Meningitis/Encephalitis (ME) Panel An Update on Malaria Rapid Diagnostic Tests A focus on improving molecular diagnostic approaches to malaria control and elimination in low 482 transmission settings: Review Diagnostic accuracy of loop-484 mediated isothermal amplification (LAMP) for screening patients with imported malaria in a non-endemic 485 setting Point-of-care testing for sexually transmitted infections: recent advances 487 and implications for disease control Point-of-care testing improves accuracy of STI care in 489 an emergency department Risk of falsely negative results with rapid HIV tests in HIV-491 infected patients Sensitivity of HIV rapid tests compared 493 with fourth-generation enzyme immunoassays or HIV RNA tests Routine HIV screening in the 495 emergency department using the new US Centers for Disease Control and Prevention Guidelines: results 496 from a high-prevalence area Clinical Utility of On-Demand Multiplex 498 Respiratory Pathogen Testing among Adult Outpatients The clinical impact of the detection of potential etiologic 500 pathogens of community-acquired pneumonia The rapid diagnosis of viral respiratory tract 502 infections and its impact on antimicrobial stewardship programs Diagnostic Stewardship: Opportunity for a Laboratory-Infectious Diseases Partnership The Value of Clinical Needs 507 Assessments for Point-of-Care Diagnostics Economic evaluation of point-of-care diagnostic technologies for infectious 509 diseases ABS-CM working group. A nationwide survey on 511 involvement of clinical microbiologists in antibiotic stewardship programmes in large French hospitals 100% H.influenza: 100% (n=1) L.monocytogenes: NA N.meningitidis: NA S.agalactiae: 0% (n=1) S.pneumoniae: 100% NA E.coli K1: 99.9% L.monocytogenes: 100% N.meningitidis: 100% S.agalactiae: 99.9% Single center Retrospective studyThe GI panel helped reduce the need for other diagnostic tests, reducing unnecessary use of antibiotics, and leading to a reduction in hospital length of stay.[51] Single center Prospective study The addition of Xpert HIV-1 Qual testing led to an increase in confirmed diagnoses by 25% (from 24 to 30 cases).[53]C. trachomatis and N. gonorrhoeae testing (PCR) Xpert (Cepheid) Single center RCT The use of Xpert CT/NG reduced overtreatment and improved adherence.[54]C. trachomatis and N. gonorrhoeae testing (PCR) Adult women (n=254)Single center RCT Xpert CT/NG reduced overtreatment and improved undertreatment of patients tested in the ED.[55]GI, Gastrointestinal; mPCR, Multiplex PCR; RADT, Rapid antigen detection test